FAM90A12 Inhibitors
Family with sequence similarity 90, member A12 (FAM90A12) is a protein encoded by a gene that belongs to a larger family of proteins characterized by having a sequence similarity within the family. Proteins within this family typically share common structural features or functional motifs that suggest a related role in cellular processes. However, the specific functions of many FAM90A proteins, including FAM90A12, have not been fully elucidated, which is not uncommon in the realm of protein families identified through genomic sequencing efforts.
Given the designation "family with sequence similarity," FAM90A12 likely shares sequence homology and possibly functional characteristics with other members of the FAM90A family. These shared sequences are often indicative of conserved roles in cellular biology, such as DNA binding, signal transduction, or interaction with other proteins. The "A12" signifies that it is one specific member of this larger family, suggesting that there are multiple paralogous proteins within this group, each with potentially distinct or overlapping functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, could indirectly influence FAM90A12 by modifying gene expression and chromatin structure. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may affect FAM90A12 indirectly by altering gene expression patterns through DNA methylation changes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, by inhibiting the proteasome, could indirectly impact FAM90A12 by affecting protein degradation pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, might influence FAM90A12 indirectly through cellular growth and proliferation pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, could affect FAM90A12 indirectly by modulating signaling pathways involved in cell survival and metabolism. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib, a JAK/STAT inhibitor, might have indirect effects on FAM90A12 by influencing gene expression and signaling pathways. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939, a Wnt/β-catenin pathway inhibitor, may indirectly impact FAM90A12 by modulating cell signaling pathways related to development and proliferation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, an inhibitor of the MAPK/ERK pathway, could indirectly affect FAM90A12 by altering signaling pathways involved in cell differentiation and growth. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG, an HSP90 inhibitor, might influence FAM90A12 indirectly by affecting protein folding and stability. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, an autophagy inhibitor, could have indirect effects on FAM90A12 through its role in cellular degradation processes. | ||||||